סכיזופרניה
הערות שוליים

↑  Kaplan and Sadock's Synopsis 2022 עמ' 359
↑  Kaplan and Sadock's Synopsis 2022 עמ' 357
1 2  Kaplan and Sadock's Synopsis 2022 עמ' 337
↑  Kaplan and Sadock's Synopsis 2022 עמ' 358
↑  Kaplan and Sadock's Synopsis 2022 עמ' 350
1 2 3 4 5  American Psychiatric Association, Schizophrenia Spectrum and other Psychotic Disorders, DSM-5 Hero Diagnostic and Statistical Manual of Mental Disorders (DSM–5), WDC: American Psychiatric Association, 2013, עמ' 99-105
↑  P.Jones,P.Buckley (2006) ע' 7
↑  M.Stone (1998) p 45-46.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30  חנן מוניץ (עורך), 9 סכיזופרניה, פרקים נבחרים בפסיכיאטריה, שישית, דיונון, 2016, עמ' 197-248. (בעברית)
↑  S.Guloksuz, J.Van Os. The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum, Psychol Med. 2018 Jan;48(2):229-244. doi: 10.1017/S0033291717001775. Epub 2017 Jul 1
↑  American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders (DSM–5), 5, American Psychiatric Association, 2013, עמ' 94-96
↑  Alexander Bryson, Helen Gardner, Ian Wilson, Tim Rolfe, Temporal lobe epilepsy following maintenance electroconvulsive therapy—Electrical kindling in the human brain?, Epilepsia 57, 2016-11-01, עמ' e216–e220 doi: 10.1111/epi.13565
↑  Felipe V. Gomes, Anthony A. Grace, Adolescent Stress as a Driving Factor for Schizophrenia Development—A Basic Science Perspective, Schizophrenia Bulletin 43, 2017-05-01, עמ' 486–489 doi: 10.1093/schbul/sbx033
↑  משרד הבריאות האגף לבריאות הנפש, שנתון בריאות הנפש 2012, משרד הבריאות האגף לבריאות הנפש, משרד הבריאות האגף לבריאות הנפש, עמ' 35
↑  Oliver D Howes, Robin M Murray, Schizophrenia: an integrated sociodevelopmental-cognitive model, The Lancet 383, 2014-05-10, עמ' 1677–1687 doi: 10.1016/S0140-6736(13)62036-X
1 2  G. Chondrou, G. P. Patrinos, E. E. Tsermpini, Qualitative meta-analysis to identify genomic variants that are correlated with the development of Schizophrenia, European Psychiatry, Abstract of the 25th European Congress of Psychiatry 41, 2017-04-01, עמ' S162 doi: 10.1016/j.eurpsy.2017.01.2039
↑  Anna Alkelai, Anna Need, Matthew Halvorsen, Lior Greenbaum, Whole Exome Sequencing In Arab And Jewish Israeli Families Multiply Affected With Schizophrenia, European Neuropsychopharmacology 27, 2017, עמ' S490–S491 doi: 10.1016/j.euroneuro.2016.09.583
↑  A. Kimberley McAllister, Major Histocompatibility Complex I in Brain Development and Schizophrenia, Biological Psychiatry, Neuroimmune Mechanisms Related to Psychosis 75, 2014-02-15, עמ' 262–268 doi: 10.1016/j.biopsych.2013.10.003
↑  Alexis C. Edwards, Silviu-Alin Bacanu, Tim B. Bigdeli, Arden Moscati, Evaluating the dopamine hypothesis of schizophrenia in a large-scale genome-wide association study, Schizophrenia Research 176, 2016-10-01, עמ' 136–140 doi: 10.1016/j.schres.2016.06.016
↑  Lena Wischhof, Ellen Irrsack, Frank Dietz, Michael Koch, Maternal lipopolysaccharide treatment differentially affects 5-HT2A and mGlu2/3 receptor function in the adult male and female rat offspring, Neuropharmacology 97, 2015-10-01, עמ' 275–288 doi: 10.1016/j.neuropharm.2015.05.029
↑  David A. Martin, Danuta Marona-Lewicka, David E. Nichols, Charles D. Nichols, Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia, Neuropharmacology 83, 2014-08-01, עמ' 1–8 doi: 10.1016/j.neuropharm.2014.03.013
↑  Wu, Hanjing Emily, Mohite, Satyajit, Ngana, Ikenna ואחרים, Hospital Length of Stay in Individuals With Schizophrenia... : The Journal of Nervous and Mental Disease, LWW doi: 10.1097/NMD.0000000000000231
↑  S. M. Nielsen, N. G. Toftdahl, M. Nordentoft, C. Hjorthøj, Association between alcohol, cannabis, and other illicit substance abuse and risk of developing schizophrenia: a nationwide population based register study, Psychological Medicine 47, 2017/07, עמ' 1668–1677 doi: 10.1017/S0033291717000162
↑  John J McGrath, Carmen C W Lim, Sukanta Saha, Cat Ownership and Schizophrenia-Related Disorders and Psychotic-Like Experiences: A Systematic Review and Meta-Analysis, Schizophrenia Bulletin 50, 2024-04-30, עמ' 489–495 doi: 10.1093/schbul/sbad168
↑  Cat Ownership and Schizophrenia: A New Perspective | Psychology Today, www.psychologytoday.com (באנגלית)
↑  Marita Pruessner, Alexis E. Cullen, Monica Aas, Elaine F. Walker, The neural diathesis-stress model of schizophrenia revisited: An update on recent findings considering illness stage and neurobiological and methodological complexities, Neuroscience & Biobehavioral Reviews 73, 2017-02-01, עמ' 191–218 doi: 10.1016/j.neubiorev.2016.12.013
↑  T. R. Kwapil, N. Barrantes-Vidal, G. M. Gross, T. Sheinbaum, Positive and negative schizotypy are associated with prodromal symptoms, schizophrenia-spectrum symptoms and personalities, and self and other schemas, Personality and Individual Differences 60, 2014-04-01, עמ' S7 doi: 10.1016/j.paid.2013.07.166
↑  Neus Barrantes-Vidal, Georgina M. Gross, Tamara Sheinbaum, Mercè Mitjavila, Positive and negative schizotypy are associated with prodromal and schizophrenia-spectrum symptoms, Schizophrenia Research 145, 2013-04-01, עמ' 50–55 doi: 10.1016/j.schres.2013.01.007
↑  Oliver D. Howes, Shitij Kapur, A neurobiological hypothesis for the classification of schizophrenia: type A (hyperdopaminergic) and type B (normodopaminergic), The British Journal of Psychiatry 205, 2014-07-01, עמ' 1–3 doi: 10.1192/bjp.bp.113.138578
↑  D. L. Braff, J. Ryan, A. J. Rissling, W. T. Carpenter, Lack of Use in the Literature From the Last 20 Years Supports Dropping Traditional Schizophrenia Subtypes From DSM-5 and ICD-11, Schizophrenia Bulletin 39, 2013-07-01, עמ' 751–753 doi: 10.1093/schbul/sbt068
↑  S. Galderisi, A. Mucci, P. Bucci, M. Maj, Characterization of different subtypes of schizophrenia: Premorbid functioning, neurophysiological differences, functional outcomes, European Psychiatry, Abstract of the 25th European Congress of Psychiatry 41, 2017-04-01, עמ' S52 doi: 10.1016/j.eurpsy.2017.01.219
↑  Anja Lehmann, Katja Bahçesular, Eva-Maria Brockmann, Sarah-Elisabeth Biederbick, Subjective experience of emotions and emotional empathy in paranoid schizophrenia, Psychiatry Research 220, 2014-12-30, עמ' 825–833 doi: 10.1016/j.psychres.2014.09.009
↑  E. Manrique-Garcia, S. Zammit, C. Dalman, T. Hemmingsson, Prognosis of schizophrenia in persons with and without a history of cannabis use, Psychological Medicine 44, 2014/09, עמ' 2513–2521 doi: 10.1017/S0033291714000191
↑  Wu, Hanjing Emily ; Mohite, Satyajit MBBS*; Ngana, Ikenna ; Burns, Wilma ; Shah, Nurun ; Schneider, Laurie ; Schmitz, Joy M. Lane, Scott D; Okusaga, Olaoluwa O., Hospital Length of Stay in Individuals With Schizophrenia... : The Journal of Nervous and Mental Disease, Journal of Nervous & Mental Disease: January 2015 - Volume 203 - Issue 1 -, עמ' 33–36 doi: 10.1097/NMD.0000000000000231
↑  Alexis C. Edwards, Tim B. Bigdeli, Anna R. Docherty, Silviu Bacanu, Meta-analysis of Positive and Negative Symptoms Reveals Schizophrenia Modifier Genes, Schizophrenia Bulletin 42, March 2016, עמ' 279–287 doi: 10.1093/schbul/sbv119
↑  Yael Adini, Yoram S. Bonneh, Seva Komm, Lisa Deutsch, The time course and characteristics of procedural learning in schizophrenia patients and healthy individuals, Frontiers in Human Neuroscience 9, 2015-09-01 doi: 10.3389/fnhum.2015.00475
↑  J. Lally, O. Ajnakina, B. Stubbs, M. Cullinane, Remission and recovery from first-episode psychosis in adults: A systematic review and meta-analysis of long-term outcome studies, European Psychiatry 41, 2017-04-01 doi: 10.1016/j.eurpsy.2017.01.1595(הקישור אינו פעיל)
1 2  Mueser, Kim T. Cook, Judith A., Rising to the challenge of first episode psychosis: The NIMH Recovery After Initial Schizophrenia Episode (RAISE) initiative., Psychiatric Rehabilitation Journal 37(4),, עמ' 267-269. doi: http://dx.doi.org/10.1037/prj0000108
↑  J. Lally, O. Ajnakina, B. Stubbs, M. Cullinane, Remission and recovery from first-episode psychosis in adults: A systematic review and meta-analysis of long-term outcome studies, European Psychiatry 41, 2017-04-01, עמ' S819 doi: 10.1016/j.eurpsy.2017.01.1595(הקישור אינו פעיל)
↑  Ruth Y Pavlovic, Aleksandar Pavlovic, Stephen Donaldson, Cochrane Database of Systematic Reviews, John Wiley & Sons, Ltd, 2016-10-04. (באנגלית)
↑  Matti Penttilä, Erika Jääskeläinen, Noora Hirvonen, Matti Isohanni, Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis, The British Journal of Psychiatry 205, 2014-08-01, עמ' 88–94 doi: 10.1192/bjp.bp.113.127753
↑  Y. Braw, R. Sitman, M. Cohen, U. Berger, Remission of positive symptoms according to the “remission in Schizophrenia Working Group” criteria: A longitudinal study of cognitive functioning, European Psychiatry 28, 2013-06-01, עמ' 282–287 doi: 10.1016/j.eurpsy.2012.04.003
↑  Tse, S., Davidson, L., Chung, K. F., Yu, C. H., Ng, K. L., & Tsoi, E., ogistic regression analysis of psychosocial correlates associated with recovery from schizophrenia in a Chinese community., International Journal of Social Psychiatry, 61(1), 2015, עמ' 50-57(הקישור אינו פעיל, 23.10.2021)
↑  Richard Warner, Recovery from Schizophrenia: Psychiatry and Political Economy, Routledge, 2013-03-01. (באנגלית)
↑  Leucht S, Measurements of response, remission, and recovery in schizophrenia and examples for their clinical application., The Journal of clinical psychiatry 75 Suppl 1, 2014 doi: 10.4088/JCP.13049su1c.02
1 2 3  Patrick McGorry, Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines for the Treatment of Schizophrenia and Related Disorders, Australian & New Zealand Journal of Psychiatry 39, 2005-01-01, עמ' 1–30 doi: 10.1080/j.1440-1614.2005.01516.x
↑  Christopher Gordon, Vasudha Gidugu, E. Sally Rogers, John DeRonck, Adapting Open Dialogue for Early-Onset Psychosis Into the U.S. Health Care Environment: A Feasibility Study, Psychiatric Services 67, 2016-07-15, עמ' 1166–1168 doi: 10.1176/appi.ps.201600271
↑  מודל סוטריה | בית במקום מוסד רפואי לחולים הפסיכיאטרים, באתר הארץ, 2 באוגוסט 2009
↑  שי קונס, TheMedical - אתר הרופאים של ישראל | הטיפול התרופתי בסכיזופרניה, באתר www.themedical.co.il, ‏2009
↑  M. Harrow, T. H. Jobe, Does Long-Term Treatment of Schizophrenia With Antipsychotic Medications Facilitate Recovery?, Schizophrenia Bulletin 39, 2013-09-01, עמ' 962–965 doi: 10.1093/schbul/sbt034
↑  סל שיקום למתמודדי נפש, באתר כל זכות
↑  תיאום טיפול, באתר www.ispraisrael.org.il (ארכיון)
↑  דיור, באתר www.ispraisrael.org.il (ארכיון)
↑  Duckworth, Kennetha,b; Halpern, Lisac, Peer support and peer-led family support for persons living ... : Current Opinion in Psychiatry, Current Opinion in Psychiatry May 2014 - Volume 27 - Issue 3, 2014, עמ' 216–221 doi: 10.1097/YCO.0000000000000051
↑  Bert-Jan Roosenschoon, Cornelis L. Mulder, Mathijs L. Deen, Jaap van Weeghel, Effectiveness of illness management and recovery (IMR) in the Netherlands: a randomised clinical trial, BMC Psychiatry 16, 2016-03-19, עמ' 73 doi: 10.1186/s12888-016-0774-0
1 2  David L. Roberts, Dennis R. Combs, Michael Willoughby, Jim Mintz, A randomized, controlled trial of Social Cognition and Interaction Training (SCIT) for outpatients with schizophrenia spectrum disorders, British Journal of Clinical Psychology 53, 2014-09-01, עמ' 281–298 doi: 10.1111/bjc.12044
1 2  David Roe, Ilanit Hasson-Ohayon, Michal Mashiach-Eizenberg, Oren Derhy, Narrative Enhancement and Cognitive Therapy (NECT) Effectiveness: A Quasi-Experimental Study, Journal of Clinical Psychology 70, 2014-04-01, עמ' 303–312 doi: 10.1002/jclp.22050
↑  סל שיקום למתמודדי נפש, באתר כל זכות
↑  אבנר אליצור, טיפול משפחתי במשפחות של חולי סכיזופרניה, באתר www.themedical.co.il, ‏2010
↑  אשפוז כפוי דחוף של מתמודדי נפש, באתר כל זכות
1 2  Susan Whitfield-Gabrieli, Clemens Bauer, Kana Okano, Paul Nestor, M64. Real Time fMRI Feedback Targeting Default Mode Network (DMN) Reduces Auditory Hallucinations, Schizophrenia Bulletin 43, 2017-03-01, עמ' S233–S233 doi: 10.1093/schbul/sbx022.059
↑  מערכת TheMEDICAL, טיפול שיאצו משפר מצבם הקליני של חולי סכיזופרניה, באתר www.themedical.co.il
↑  Alan B. McGuire, Marina Kukla, Amethyst Green, Daniel Gilbride, Illness Management and Recovery: A Review of the Literature, Psychiatric Services 65, 2014-02-01, עמ' 171–179 doi: 10.1176/appi.ps.201200274
↑  Jessica A. Jonikas, Dennis D. Grey, Mary Ellen Copeland, Lisa A. Razzano, Improving Propensity for Patient Self-Advocacy Through Wellness Recovery Action Planning: Results of a Randomized Controlled Trial, Community Mental Health Journal 49, 2013-06-01, עמ' 260–269 doi: 10.1007/s10597-011-9475-9
↑  Mark J. Millan, Annie Andrieux, George Bartzokis, Kristin Cadenhead, Altering the course of schizophrenia: progress and perspectives, Nature Reviews Drug Discovery 15, July 2016, עמ' 485–515 doi: 10.1038/nrd.2016.28
↑  Thomas Munk Laursen, Merete Nordentoft, Preben Bo Mortensen, Excess Early Mortality in Schizophrenia, Annual Review of Clinical Psychology 10, 2014-03-28, עמ' 425–448 doi: 10.1146/annurev-clinpsy-032813-153657
1 2  NIMH Study To Guide Treatment Choices for Schizophrenia, PsycEXTRA Dataset, ‏2005
↑  Leonard Kritharides, Vincent Chow, Tim JR Lambert, Cardiovascular disease in patients with schizophrenia, Medical Journal of Australia 206, 2017-02, עמ' 91–95 doi: 10.5694/mja16.00650
1 2  Sabine M. J. M. Straus, Gysèle S. Bleumink, Jeanne P. Dieleman, Johan van der Lei, Antipsychotics and the Risk of Sudden Cardiac Death, Archives of Internal Medicine 164, 2004-06-28 doi: 10.1001/archinte.164.12.1293
1 2  F Salvo, A Pariente, S Shakir, P Robinson, Sudden cardiac and sudden unexpected death related to antipsychotics: A meta-analysis of observational studies, Clinical Pharmacology & Therapeutics 99, 2016-03-01, עמ' 306–314 doi: 10.1002/cpt.250
↑  Richard Musil, Michael Obermeier, Paul Russ, Michael Hamerle, Weight gain and antipsychotics: a drug safety review, Expert Opinion on Drug Safety 14, 2015-01-02, עמ' 73–96 doi: 10.1517/14740338.2015.974549
↑  גיא שוסהיים, TheMedical - אתר הרופאים של ישראל | סכיזופרניה והשמנה, באתר www.themedical.co.il, ‏2008
↑  Annette Erlangsen, William W. Eaton, Preben Bo Mortensen, Yeates Conwell, Schizophrenia — A predictor of suicide during the second half of life?, Schizophrenia Research 134, 2012-02, עמ' 111–117 doi: 10.1016/j.schres.2011.09.032
1 2  A. Fleischman, N. Werbeloff, R. Yoffe, M. Davidson, Schizophrenia and violent crime: a population-based study, Psychological Medicine 44, October 2014, עמ' 3051–3057 doi: 10.1017/S0033291714000695
↑  2000 R.Cancro, H.E.Lehmann ע' 1192-1193
↑  ורדה ליברמן ועמוס טברסקי, 9 התמדת אמונות, חשיבה ביקורתית: שיקולים סטטיסטיים ושיפוט אינטואיטיבי, האוניברסיטה הפתוחה, 1996, עמ' 210
↑  Sheilagh Hodgins, SA Mednick,PA Brennan, F Schulsinger, M Engberg: Mental disorder and crime. Evidence from a Danish birth cohort Arch Gen Psychiatry 1996 Jun (53)6 489-496
↑  A.Fleischman et al 2014
1 2  Seena Fazel, Niklas Långström, Anders Hjern, Martin Grann, Schizophrenia, substance abuse, and violent crime, JAMA 301, 2009-05-20, עמ' 2016–2023 doi: 10.1001/jama.2009.675
↑  Seena Fazel, Achim Wolf, Camilla Palm, Paul Lichtenstein, Violent crime, suicide, and premature mortality in patients with schizophrenia and related disorders: a 38-year total population study in Sweden, The Lancet Psychiatry 1, 2014-06-01, עמ' 44–54 doi: 10.1016/S2215-0366(14)70223-8
↑  Linda A Teplin et al 2005 Arch Gen Psychiatry Aug 62(8) pp.911-921
↑  לחיות עם סכיזופרניה עמותת אנוש
↑  אמיר בוגן, ניו יורק, נילס ארדן אופלב: "אפשר להגיד שכקולנוען גם אני סובל מסכיזופרניה", באתר ynet, 28 ביוני 2023
| --- | --- |
בקרת זהויות :  NLI: 987007560704805171  BnF: cb119458692 (data)  GND: 4052527-2  LCCN: sh85118162  NDL: 00570393  NKC: ph125438  NSK: 000227242 
הבהרה: המידע בוויקיפדיה נועד להעשרה בלבד ואינו מהווה ייעוץ רפואי.
אויגן בלוילר, פסיכיאטר שווייצרי שטבע את המונח "סכיזופרניה"
ספרו של בלוילר "דמנציה פרקוקס או קבוצת הסכיזופרניות", במהדורה משנת 1911
מחקר PET מציע שככל שהאונה המצחית פחות פעילה (אדום) במהלך מטלה של זיכרון העבודה, העלייה בפעילות הדופמין החריגה בסטריאטום גדולה יותר (ירוק). דבר זה נחשב לגרעון נוירו־קוגניטיבי בסכיזופרניה.
ריספרדל, תרופה נפוצה נגד פסיכוזה